All pairs

Ergotamine and nelfinavir

Desk tier: Avoid together

Mechanism: strong CYP3A4 inhibition of clearance (↑ exposure)

“Coadministration of ergotamine with potent CYP 3A4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, and troleandomycin) … ergotamine use is contraindicated with these drugs”
Cafergot (ergotamine/caffeine), section CONTRAINDICATIONS. DailyMed label
Why this grade

Cafergot (ergotamine/caffeine) label, Contraindications

The Cafergot (ergotamine/caffeine) label lists this combination under Contraindications. CONTRAINDICATIONS: "Coadministration of ergotamine with potent CYP 3A4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, and troleandomycin) … ergotamine use is contraindicated with these drugs" Named in the label: "nelfinavir" Retrieved from DailyMed 2026-10-12.

Cafergot (ergotamine/caffeine) label on DailyMed

FDA interaction table

FDA's example-interaction table lists nelfinavir as a strong CYP3A inhibitor. FDA grades the roles; the severity tier on this row is the desk's rule. Table content current as of 2026-05-29.

FDA interaction table

Open this pair in the desk

All pairs for Ergotamine · nelfinavir

Enzyme behind this pair: CYP3A4

Educational reference only. Not FDA-cleared. The Prescribing Information governs.

Drug and product names are trademarks of their owners and are used only to identify the products.